Michael Schlander

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Systematic Review

Papillary Thyroid

High Performance Liquid Chromatography

Top Venues

PharmacoEconomics

Health care analysis : HCA : journal of health philosophy and policy

International journal of health policy and management

This page only lists publications with an associated author ORCID identifier.

Publications

Muchandifunga Trust Muchadeyi, Karla Hernandez-Villafuerte, Gian Luca Di Tanna, Rachel D Eckford, Yan Feng, Michela Meregaglia, Tessa Peasgood, Stavros Petrou, Jasper Ubels, Michael Schlander
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations. PharmacoEconomics 42 (7) (2024)
Jasper Ubels, Karla Hernandez-Villafuerte, Erica Niebauer, Michael Schlander
The Use of a Comprehensive Concept of Capability for Wellbeing Assessment: A Best-Fit Framework Synthesis. Health care analysis : HCA : journal of health philosophy and policy (2024)
Muchandifunga Trust Muchadeyi, Karla Hernandez-Villafuerte, Gian Luca Di Tanna, Rachel D Eckford, Yan Feng, Michela Meregaglia, Tessa Peasgood, Stavros Petrou, Jasper Ubels, Michael Schlander
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations. PharmacoEconomics 42 (7) (2024)
Muchandifunga Trust Muchadeyi, Karla Hernandez-Villafuerte, Gian Luca Di Tanna, Rachel D Eckford, Yan Feng, Michela Meregaglia, Tessa Peasgood, Stavros Petrou, Jasper Ubels, Michael Schlander
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations. PharmacoEconomics (2024)
Muchandifunga Trust Muchadeyi, Karla Hernandez-Villafuerte, Gian Luca Di Tanna, Rachel D Eckford, Yan Feng, Michela Meregaglia, Tessa Peasgood, Stavros Petrou, Jasper Ubels, Michael Schlander
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations. PharmacoEconomics 42 (7) (2024)
Muchandifunga Trust Muchadeyi, Karla Hernandez-Villafuerte, Gian Luca Di Tanna, Rachel D Eckford, Yan Feng, Michela Meregaglia, Tessa Peasgood, Stavros Petrou, Jasper Ubels, Michael Schlander
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations. PharmacoEconomics 42 (7) (2024)
Phu Duy Pham, Michael Schlander, Rachel D Eckford, Karla Hernandez-Villafuerte, Jasper Ubels
Developing a Conceptual Framework for Socioeconomic Impact Research in European Cancer Patients: A 'Best-Fit' Framework Synthesis. The patient (2023)
Jasper Ubels, Michael Schlander
Measurement invariance and adapted preferences: evidence for the ICECAP-A and WeRFree instruments. Health and quality of life outcomes 21 (1) (2023)
Michael Schlander, Karla Hernandez-Villafuerte, Chih-Yuan Cheng, Jorge Mestre-Ferrandiz, Michael Baumann
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment. PharmacoEconomics 39 (11) (2021)
Ramon Schaefer, Diego Hernandez, Lorenz Selberg, Michael Schlander
Health technology assessment (HTA) in England, France and Germany: what do matched drug pairs tell us about recommendations by national HTA agencies? Journal of comparative effectiveness research 10 (16) (2021)
Michael Schlander
HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe". International journal of health policy and management 10 (3) (2021)
Jeffrey Richardson, Michael Schlander
Health technology assessment (HTA) and economic evaluation: efficiency or fairness first. Journal of market access & health policy 7 (1) (2018)